GENEVA, Oct. 1 -- ACERNA TECHNOLOGIES CO., LTD. filed a patent application (JP2026/009773) for “RNA NUCLEIC ACID MOLECULE, LIPID NUCLEIC ACID COMPLEX, PHARMACEUTICAL COMPOSITION, AND METHOD FOR INDUCING EXPRESSION OF GENE OF INTEREST USING MIRNA”. With publication no. WO/2026/192033, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....